Dr David Dodwell
David Dodwell
BSc, MD, FRCP, FRCR
Senior Clinical Research Fellow
David is a senior breast oncologist with a number of research and governance interests.
He is the lead oncologist on the Sloane and NHS breast screening audits and co-lead for the national audits in primary and metastatic breast cancer.
Recent publications
Real-world obesity prevalence and history in 79 271 patients receiving systemic anticancer therapy across 13 cancer types in England (2013-2023).
Journal article
Perletta V. et al, (2026), ESMO Real World Data Digit Oncol, 12
Age, patient experience and satisfaction with breast cancer care: a cohort study using linked national cancer patient experience survey and cancer registry data.
Journal article
Blacker S. et al, (2026), BMJ Open, 16
Effects of ovarian ablation or suppression on breast cancer recurrence and survival: patient-level meta-analysis of 15 000 women in 23 randomised trials.
Journal article
Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Electronic address: bc.overview@ndph.ox.ac.uk . and Early Breast Cancer Trialists' Collaborative Group (EBCTCG) ., (2026), Lancet, 407, 1699 - 1711
The National Audit of Metastatic Breast Cancer (NAoMe): Sharing Key Findings and Recommendations From the 2025 State of the Nation Report.
Journal article
Hanbury G. et al, (2026), Clin Oncol (R Coll Radiol), 52
Reducing locoregional treatments in low risk early invasive breast cancer.
Journal article
Potter S. et al, (2026), Eur J Surg Oncol, 52